Machine-learning score to predict in-hospital outcomes in patients Hospitalized in Intensive Cardiac Care Unit

IF 35.6 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS European Heart Journal Pub Date : 2023-11-11 DOI:10.1093/eurheartj/ehad655.1583
O Weizman, T Pezel, K Hamzi, G Schurtz, M Hauguel-Moreau, A Trimaille, S Toupin, T Bochaton, S Attou, C Meune, F Boccara, B Pasdeloup, Y El Ouahidi, J G Dillinger, P Henry
{"title":"Machine-learning score to predict in-hospital outcomes in patients Hospitalized in Intensive Cardiac Care Unit","authors":"O Weizman, T Pezel, K Hamzi, G Schurtz, M Hauguel-Moreau, A Trimaille, S Toupin, T Bochaton, S Attou, C Meune, F Boccara, B Pasdeloup, Y El Ouahidi, J G Dillinger, P Henry","doi":"10.1093/eurheartj/ehad655.1583","DOIUrl":null,"url":null,"abstract":"Background While few scores are available for risk stratification of patients hospitalized in Intensive Cardiac Care Unit (ICCU) using traditional statistical methods, the potential benefit of machine learning is not established. Purpose To investigate the feasibility and accuracy of machine-learning (ML) to predict in-hospital major adverse events (MAE) in patients hospitalized in ICCU and compare its performance with existing scores. Methods From April 7 to 22, 2021, a French nationwide, multicenter, prospective, study involving 39 centers included all consecutive patients admitted in ICCU (N=1499). The primary outcome was in-hospital MAE defined as a composite outcome including all-cause in-hospital mortality, cardiogenic shock and resuscitated cardiac arrest (severe ventricular arrhythmia requiring defibrillation or anti-arrhythmic agents). Twenty-eight clinical, biological, ECG, and echocardiographic variables were considered for the Boruta variable selection algorithm. Using 31 centers randomly as an index cohort, several ML algorithms (logistic regression, ridge regression, boosted cost-sensitive C5.0 and XGBoost. C5.0 ) were evaluated to build a ML-score to predict in-hospital MAE. The other 8 centers formed the external validation cohort of the ML-score. Results Among 1499 consecutive patients included (age 63.3±14.9 years, 69.6% male), 61 had in-hospital MAE (4.3%). Out of 28 variables included in the feature selection, seven were selected as of particular importance to predict MAE in the training set (N=844) including: illicit drug use, mean arterial pressure, Killip stage, exhaled CO level, left ventricular ejection fraction, TAPSE value and peak E/e’ ratio. Boosted cost-sensitive C5.0 technique showed the best performance compared with other ML-techniques (area under the curve [AUC]=0.90, PR-AUC=0.57, F1 score=0.5), using 5 of the 7 above mentioned variables: mean arterial pressure, exhaled CO level, left ventricular ejection fraction, TAPSE value and peak E/e’ ratio. Our ML-score exhibited a higher AUC compared with existing scores for MAE prediction (ML score: 0.90 vs TIMI-score: 0.56, GRACE-score: 0.52, Acute HF-score: 0.65; all p<0.001). ML-score also exhibited a good AUC in the external cohort (AUC 0.97). Conclusions Including five simple clinical and echocardiographic variables (mean arterial pressure, exhaled CO level, left ventricular ejection fraction, TAPSE value and peak E/e’ ratio) routinely assessed in patients admitted in ICCU, the ML score exhibited a better prognostic value to predict in-hospital outcomes compared with existing scores.ML model and existing scores: ROC curveML model and existing scores: PR curve","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"42 4","pages":""},"PeriodicalIF":35.6000,"publicationDate":"2023-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/eurheartj/ehad655.1583","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background While few scores are available for risk stratification of patients hospitalized in Intensive Cardiac Care Unit (ICCU) using traditional statistical methods, the potential benefit of machine learning is not established. Purpose To investigate the feasibility and accuracy of machine-learning (ML) to predict in-hospital major adverse events (MAE) in patients hospitalized in ICCU and compare its performance with existing scores. Methods From April 7 to 22, 2021, a French nationwide, multicenter, prospective, study involving 39 centers included all consecutive patients admitted in ICCU (N=1499). The primary outcome was in-hospital MAE defined as a composite outcome including all-cause in-hospital mortality, cardiogenic shock and resuscitated cardiac arrest (severe ventricular arrhythmia requiring defibrillation or anti-arrhythmic agents). Twenty-eight clinical, biological, ECG, and echocardiographic variables were considered for the Boruta variable selection algorithm. Using 31 centers randomly as an index cohort, several ML algorithms (logistic regression, ridge regression, boosted cost-sensitive C5.0 and XGBoost. C5.0 ) were evaluated to build a ML-score to predict in-hospital MAE. The other 8 centers formed the external validation cohort of the ML-score. Results Among 1499 consecutive patients included (age 63.3±14.9 years, 69.6% male), 61 had in-hospital MAE (4.3%). Out of 28 variables included in the feature selection, seven were selected as of particular importance to predict MAE in the training set (N=844) including: illicit drug use, mean arterial pressure, Killip stage, exhaled CO level, left ventricular ejection fraction, TAPSE value and peak E/e’ ratio. Boosted cost-sensitive C5.0 technique showed the best performance compared with other ML-techniques (area under the curve [AUC]=0.90, PR-AUC=0.57, F1 score=0.5), using 5 of the 7 above mentioned variables: mean arterial pressure, exhaled CO level, left ventricular ejection fraction, TAPSE value and peak E/e’ ratio. Our ML-score exhibited a higher AUC compared with existing scores for MAE prediction (ML score: 0.90 vs TIMI-score: 0.56, GRACE-score: 0.52, Acute HF-score: 0.65; all p<0.001). ML-score also exhibited a good AUC in the external cohort (AUC 0.97). Conclusions Including five simple clinical and echocardiographic variables (mean arterial pressure, exhaled CO level, left ventricular ejection fraction, TAPSE value and peak E/e’ ratio) routinely assessed in patients admitted in ICCU, the ML score exhibited a better prognostic value to predict in-hospital outcomes compared with existing scores.ML model and existing scores: ROC curveML model and existing scores: PR curve
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
机器学习评分用于预测心脏重症监护病房住院患者的住院结果
虽然使用传统统计方法对重症心脏监护病房(ICCU)住院患者进行风险分层的评分很少,但机器学习的潜在益处尚未确定。目的探讨机器学习(ML)预测icu住院患者院内重大不良事件(MAE)的可行性和准确性,并与现有评分进行比较。方法2021年4月7日至22日,法国一项涉及39个中心的全国性、多中心、前瞻性研究纳入了所有连续入住ICCU的患者(N=1499)。主要终点是院内MAE,定义为包括全因院内死亡率、心源性休克和复苏性心脏骤停(需要除颤或抗心律失常药物的严重室性心律失常)在内的复合终点。博鲁塔变量选择算法考虑了28个临床、生物学、心电图和超声心动图变量。随机选取31个中心作为索引队列,采用几种机器学习算法(逻辑回归、脊回归、增强成本敏感C5.0和XGBoost)。C5.0),建立预测院内MAE的ml评分。其余8个中心组成ml评分的外部验证队列。结果连续纳入1499例患者(年龄63.3±14.9岁,男性69.6%),其中61例(4.3%)发生院内MAE。在纳入特征选择的28个变量中,有7个被认为对预测训练集中MAE特别重要(N=844),包括:非法药物使用、平均动脉压、Killip分期、呼出CO水平、左室射血分数、TAPSE值和峰值E/ E’比。使用上述7个变量中的5个:平均动脉压、呼气CO水平、左室射血分数、TAPSE值和峰值E/ E′比,增强成本敏感C5.0技术与其他ml技术相比表现最佳(曲线下面积[AUC]=0.90, PR-AUC=0.57, F1评分=0.5)。与现有的MAE预测评分相比,我们的ML评分显示出更高的AUC (ML评分:0.90 vs timi评分:0.56,grace评分:0.52,急性hf评分:0.65;所有p&肝移植;0.001)。ML-score在外部队列中也表现出良好的AUC (AUC 0.97)。结论包括5个简单的临床和超声心动图变量(平均动脉压、呼出CO水平、左室射血分数、TAPSE值和峰值E/ E’比),与现有评分相比,ML评分在预测住院患者预后方面具有更好的价值。ML模型和现有得分:ROC曲线;ML模型和现有得分:PR曲线
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
European Heart Journal
European Heart Journal 医学-心血管系统
CiteScore
39.30
自引率
6.90%
发文量
3942
审稿时长
1 months
期刊介绍: The European Heart Journal is a renowned international journal that focuses on cardiovascular medicine. It is published weekly and is the official journal of the European Society of Cardiology. This peer-reviewed journal is committed to publishing high-quality clinical and scientific material pertaining to all aspects of cardiovascular medicine. It covers a diverse range of topics including research findings, technical evaluations, and reviews. Moreover, the journal serves as a platform for the exchange of information and discussions on various aspects of cardiovascular medicine, including educational matters. In addition to original papers on cardiovascular medicine and surgery, the European Heart Journal also presents reviews, clinical perspectives, ESC Guidelines, and editorial articles that highlight recent advancements in cardiology. Additionally, the journal actively encourages readers to share their thoughts and opinions through correspondence.
期刊最新文献
Long-term safety and efficacy of aficamten in the evolving era of myosin inhibition for obstructive hypertrophic cardiomyopathy. Great debate: preventive percutaneous coronary intervention added to optimal medical treatment should be the default treatment for non-flow-limiting vulnerable plaques. All obesity is not created equal: implications for NP-agnostic HFpEF enrichment using the HFpEF-ABA score. Novel cardiovascular metabolic risk factor mechanisms and therapeutic opportunities. Laminopathies: natural history and risk prediction of heart failure.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1